Advertisement
Screener

HARVARD BIOSCIENCE, INC. (HBIO) Deferred Income Tax Liabilities, Net

1.6 / 5 stars · 26/82 Roast Me

HARVARD BIOSCIENCE, INC. Deferred Income Tax Liabilities, Net

HARVARD BIOSCIENCE, INC. (HBIO) had Deferred Income Tax Liabilities, Net of $311.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-11

  • 2026-06-30: Deferred Income Tax Liabilities, Net $311.00K.
  • 2026-03-31: Deferred Income Tax Liabilities, Net $313.00K.
  • 2025-12-31: Deferred Income Tax Liabilities, Net $317.00K.
  • 2025-09-30: Deferred Income Tax Liabilities, Net $733.00K.
Period endDeferred Income Tax Liabilities, Net
2026-06-30$311.00K
10-Q · filed 2026-08-11
2026-03-31$313.00K
10-Q · filed 2026-05-12
2025-12-31$317.00K
10-Q · filed 2026-08-11
2025-09-30$733.00K
10-Q · filed 2025-11-06
2025-06-30$734.00K
10-Q · filed 2025-08-11
2025-03-31$717.00K
10-Q · filed 2025-05-12
2024-12-31$710.00K
10-K · filed 2026-03-13
2024-09-30$707.00K
10-Q · filed 2024-11-08
2024-06-30$764.00K
10-Q · filed 2024-08-08
2024-03-31$772.00K
10-Q · filed 2024-05-07
2023-12-31$776.00K
10-K · filed 2025-03-14
2023-09-30$661.00K
10-Q · filed 2023-11-07
2023-06-30$667.00K
10-Q · filed 2023-08-08
2023-03-31$546.00K
10-Q · filed 2023-04-26
2022-12-31$590.00K
10-K · filed 2024-03-07
2022-09-30$1.18M
10-Q · filed 2022-11-09
2022-06-30$2.43M
10-Q · filed 2022-08-04
2022-03-31$1.44M
10-Q · filed 2022-05-04
2021-12-31$1.56M
10-K · filed 2023-03-09
2021-09-30$1.55M
10-Q · filed 2021-11-05
2021-06-30$1.57M
10-Q · filed 2021-08-06
2021-03-31$1.81M
10-Q · filed 2021-05-07
2020-12-31$1.90M
10-K · filed 2022-03-11
2020-09-30$1.91M
10-Q · filed 2020-11-06
2020-06-30$2.28M
10-Q · filed 2020-08-10
2020-03-31$1.77M
10-Q · filed 2020-05-08
2019-12-31$1.97M
10-K/A · filed 2021-03-17
2018-12-31$2.30M
10-K · filed 2020-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Precipio, Inc. (PRPO)United States$0.043B-36.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15